NPPB and hydrops fetalis: Currently, the only recommended biomarkers in this regard are NT-BNP, NT-proBNP, and highly-sensitive C-reactive protein (hs-CRP), whose elevated levels can predict the prognosis of HF patients to some extent, but still have great limitations and cannot accurately determine patient's prognosis.